Literature DB >> 7682129

5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.

M I Colado1, T K Murray, A R Green.   

Abstract

1. The present study has investigated whether the neurotoxic effects of the relatively selective 5-hydroxytryptamine (5-HT) neurotoxins, 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy'), p-chloroamphetamine (PCA) and fenfluramine on hippocampal and cortical 5-HT terminals in rat brain could be prevented by administration of either chlormethiazole or dizocilpine. 2. Administration of MDMA (20 mg kg-1, i.p.) resulted in an approximate 30% loss of cortical and hippocampal 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) content 4 days later. Injection of chlormethiazole (50 mg kg-1) 5 min before and 55 min after the MDMA provided complete protection in both regions, while dizocilpine (1 mg kg-1, i.p.) protected only the hippocampus. 3. Administration of a single dose of chlormethiazole (100 mg kg-1) 20 min after the MDMA also provided complete protection to the hippocampus but not the cortex. This regime also attenuated the sustained hyperthermia (approx +2.5 degrees C) induced by the MDMA injection. 4. Injection of PCA (5 mg kg-1, i.p.) resulted in a 70% loss of 5-HT and 5-HIAA content in hippocampus and cortex 4 days later. Injection of chlormethiazole (100 mg kg-1, i.p.) or dizocilpine (1 mg kg-1, i.p.) 5 min before and 55 min after the PCA failed to protect against the neurotoxicity, nor was protection afforded by chlormethiazole when a lower dose of PCA (2.5 mg kg-1, i.p.) was given which produced only a 30% loss of 5-HT content. Chlormethiazole did prevent the hyperthermia induced by PCA (5 mg kg-1), while the lower dose of PCA (2.5 mg kg-1) did not produce a change in body temperature.5. Neither chlormethiazole nor dizocilpine prevented the neurotoxic loss of hippocampal or cortical 5-HT neurones measured 4 days following administration of fenfluramine (25 mg kg-1, i.p.).6. In general, chlormethiazole and dizocilpine were effective antagonists of the 5-HT-mediated behaviours of head weaving and forepaw treading which appeared following injection of all three neurotoxins.7. Both chlormethiazole and dizocilpine have previously been shown to prevent the neurotoxic effects ofa high dose of methamphetamine on cerebral 5-HT and dopamine pathways. These drugs also prevent MDMA-induced neurotoxicity of 5-HT pathways, but not that induced by injection of PCA or fenfluramine. This suggests that the mechanisms of neurotoxic damage to 5-HT pathways produced by substituted amphetamines cannot be identical. The monoamine loss does not appear to result from the hyperthermia produced by the neurotoxic compounds.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682129      PMCID: PMC1908028          DOI: 10.1111/j.1476-5381.1993.tb12846.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Role of dopamine in the neurotoxic effects of methamphetamine.

Authors:  C J Schmidt; J K Ritter; P K Sonsalla; G R Hanson; J W Gibb
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

2.  Long-term effects of p-chloroamphetamine on tryptophan hydroxylase activity and on the levels of 5-hydroxytryptamine and 5-hydroxyindole acetic acid in brain.

Authors:  E Sanders-Bush; J A Bushing; F Sulser
Journal:  Eur J Pharmacol       Date:  1972-12       Impact factor: 4.432

3.  Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil.

Authors:  R Gill; A C Foster; G N Woodruff
Journal:  J Neurosci       Date:  1987-10       Impact factor: 6.167

4.  Selective (+)-amphetamine neurotoxicity on striatal dopamine nerve terminals in the mouse.

Authors:  G Jonsson; E Nwanze
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

5.  The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

Authors:  E H Wong; J A Kemp; T Priestley; A R Knight; G N Woodruff; L L Iversen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.

Authors:  U V Berger; X F Gu; E C Azmitia
Journal:  Eur J Pharmacol       Date:  1992-05-14       Impact factor: 4.432

7.  Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain.

Authors:  G A Ricaurte; R W Guillery; L S Seiden; C R Schuster; R Y Moore
Journal:  Brain Res       Date:  1982-03-04       Impact factor: 3.252

8.  Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.

Authors:  J F Nash; H Y Meltzer; G A Gudelsky
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

9.  The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

Authors:  D M Stone; D C Stahl; G R Hanson; J W Gibb
Journal:  Eur J Pharmacol       Date:  1986-08-22       Impact factor: 4.432

10.  Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

Authors:  C J Schmidt
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

View more
  35 in total

1.  Does recreational ecstasy use cause long-term cognitive problems?

Authors:  P A Kelly
Journal:  West J Med       Date:  2000-08

2.  Investigation of the mechanisms mediating MDMA "Ecstasy"-induced increases in cerebro-cortical perfusion determined by btASL MRI.

Authors:  J Rouine; M E Kelly; C Jennings-Murphy; P Duffy; I Gorman; S Gormley; C M Kerskens; Andrew Harkin
Journal:  Psychopharmacology (Berl)       Date:  2014-11-01       Impact factor: 4.530

3.  On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA.

Authors:  A Richard Green; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2002-08       Impact factor: 4.530

Review 4.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

5.  Ecstasy and neurodegeneration. No evidence of neurotoxicity exists.

Authors:  N Saunders
Journal:  BMJ       Date:  1996-08-17

6.  In vivo [¹⁸F] FDG PET imaging reveals that p-chloroamphetamine neurotoxicity is associated with long-term cortical and hippocampal hypometabolism.

Authors:  Luis García-García; Mercedes Delgado; Ahmed Anis Al-Sayed; Pablo Bascuñana; Rubén Fernández de la Rosa; Paloma Bermejo-Bescós; Sagrario Martín-Aragón; Miguel A Pozo
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

7.  Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.

Authors:  Q David Walker; Christina N Williams; Rakesh P Jotwani; Samuel T Waller; Reynold Francis; Cynthia M Kuhn
Journal:  Psychopharmacology (Berl)       Date:  2006-09-23       Impact factor: 4.530

8.  Chlormethiazole attenuates the derangement of sensory evoked potential (SEP) induced by ICV administration of NMDA.

Authors:  P Thoren; M Sjölander
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 9.  Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.

Authors:  M Isabel Colado; Esther O'Shea; A Richard Green
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

10.  Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine.

Authors:  H A Baldwin; M I Colado; T K Murray; R J De Souza; A R Green
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.